Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

RTI Surgical Inc (NASDAQ:RTIX)

Delayed Data
As of Oct 06
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

RTI Surgical, Inc. is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. The company recovers and processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine animal tissue in producing allograft and xenograft implants utilizing proprietary BIOCLEANSE and TUTOPLAST sterilization processes, for distribution to hospitals and surgeons. It produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues, and improve surgical outcomes. The company's business lines are comprised of five categories: Sports Medicine, Spine, Surgical Specialties, Bone Graft Substitutes & General Orthopedic, and Dental. The Sports Medicine business category's implants and products include BioCleanse Meniscus, Bone-Tendon-Bone Select, BioCleanse Peroneus Longus, Sterling Xenograft Wedge, osteochondral and Matrix HD. Its allografts are tendons for ligament reconstruction and meniscal allografts are for transplantation. The Spine business includes precision machined implants and bone paste utilized in spinal procedures. The Surgical Specialties business distributes implants for hernia, breast reconstruction, urology, ophthalmology, and ENT. The orthopedic business includes General Orthopedic and Trauma Allografts and Bone Graft Substitutes. The Dental business provides various implants including cancellous and cortical bone and human and bovine membranes primarily for dental procedures related to augmenting ridge restoration. The company was founded in August 2000 and is headquartered in Alachua, FL.

Contact Information

RTI Surgical, Inc.
11621 Research Circle
Alachua Florida 32615
P:(386) 418-8888
Investor Relations:



Other institutional50.07%
Mutual fund holders22.11%
Individual stakeholders11.75%

Top Executives

Brian K. HutchisonPresident, Chief Executive Officer & Director
Robert P. JordheimCFO, Executive VP & Head-Investor Relations
Caroline A. HartillChief Scientific Officer & Executive VP
Lennox K. ArchibaldMedical Director
Christopher R. GingrasDirector-Corporate Compliance